Literature DB >> 6883097

Involvement of central muscarinic cholinergic mechanisms in opioid stress analgesia.

J W Lewis, J T Cannon, J C Liebeskind.   

Abstract

Stress has been shown capable of differentially activating opioid- and non-opioid-mediated endogenous analgesia systems. In this study, the muscarinic cholinergic antagonist, scopolamine, but not the centrally inactive methylscopolamine, blocks opioid, but not non-opioid stress analgesia. Additionally, naltrexone, an opiate antagonist, attenuates analgesia induced by oxotremorine, a cholinergic agonist. These findings support the existence of a muscarinic cholinergic synapse in a central nervous system opioid pain-inhibitory pathway.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6883097     DOI: 10.1016/0006-8993(83)90603-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Reduction of oxotremorine-induced analgesia after chronic but not acute restraint stress.

Authors:  A Badiani; F Pavone
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Selective potentiations in opioid analgesia following scopolamine pretreatment.

Authors:  E S Sperber; M T Romero; R J Bodnar
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Involvement of hippocampal acetylcholinergic receptors in electroacupuncture analgesia in neuropathic pain rats.

Authors:  Shu Ping Chen; Yu Kan; Jian Liang Zhang; Jun Ying Wang; Yong Hui Gao; Li Na Qiao; Xiu Mei Feng; Ya Xia Yan; Jun Ling Liu
Journal:  Behav Brain Funct       Date:  2016-04-12       Impact factor: 3.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.